21 CFR 862.3380

§ 862.3380 Ethosuximide test system.

United States · 21 CFR — Food and Drugs · Status: effective

Cite this

Citation: 21 CFR 862.3380, § 862.3380 Ethosuximide test system, United States, version 1 as recorded 2026-07-09, yourstate.us, https://yourstate.us/provision/89264
Permanent ID: ys:prov:89264@1
SHA-256: 3d6d114fa1534c96eae06f74ca776accae999af68529c4f8b81c9fe108ba9ba8

The hash is SHA-256 of this version's text, with every run of whitespace collapsed to a single space and the ends trimmed. The ID always leads back here, and checking it says whether the text you cited is still the current version.

Full text

(a) Identification. An ethosuximide test system is a device intended to measure ethosuximide, an antiepileptic drug, in human specimens. Measurements obtained by this device are used in the diagnosis and treatment of ethosuximide overdose and in monitoring levels of ethosuximide to ensure appropriate therapy. (b) Classification. Class II.

Legislative history

This is a federal regulation, adopted through agency rulemaking under the Administrative Procedure Act — not enacted by a recorded vote of Congress.